New women's hair care brand 'HIMERI' launches in Japan, offering LINE hair analysis and upcoming hair regrowth medication

Overview MBOX Inc., with the mission of 'innovating self-medication through technology,' has launched 'HIMERI,' a brand dedicated to women's hair care. The first service, a dermatologist-supervised LINE hair analysis, has been introduced.

Additionally, the company plans to release 'HIMERI Minoki 1%' (a Class 1 pharmaceutical), a hair regrowth agent for women containing 1% minoxidil, this summer. The brand aims to provide end-to-end support for women's hair care, covering everything from hair analysis to purchase and continuous support.

Background A survey by MBOX targeting 500 women aged 40-50 revealed that 61.3% of women concerned about thinning hair have 'never consulted anyone.' The primary reason was not embarrassment, but resignation, with 49.3% stating, 'It's unavoidable due to aging.' Even among those taking measures, about 70% do not feel effective results, and only 4.2% of women have used minoxidil-containing hair regrowth agents. 'HIMERI' was created to solve these three challenges: 'cannot consult,' 'do not know the correct options,' and 'do not feel effective results.'

Services provided by HIMERI - Hair Analysis: Understand hair thinning types and receive optimal care suggestions via LINE. - Product Proposal & Purchase: Receive product recommendations based on results and purchase directly via smartphone. - Clinic Referrals: Guidance for in-person consultations when necessary. - Pharmacist Consultation: Consult anytime about medication interactions or side effects.

Details of LINE Hair Analysis - Cost: Free - Supervision: Dr. Maaya Konishi, Director of Sugamo Sengoku Dermatology - Features: Logic supervised by a dermatologist, completely private environment, and continuous delivery of educational content supervised by doctors and pharmacists.